Humulin R
Hyperandrogenism
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y CajalDormant
D
30/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 15/ 100
- Competitive Position
- 89/ 100
Competitive context
2 Active assets in the Hyperandrogenism cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Drospirenone Tyumen State Medical Academy | Phase 4 | BB |
Letrozole Attikon Hospital | Phase 3 | BB |
LEUPROLIDE National Center for Research Resources (NCRR) | Phase 2 | B |
Clomifene Semnan University of Medical Sciences | Phase 2 | CCC |
CHORIOGONADOTROPIN ALPHA University of Virginia | N/A | D |
DEXAMETHASONE University of Virginia | N/A | D |
Levonorgestrel Attikon Hospital | D |
Same molecule, other indications
Humulin R is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →